XML 114 R70.htm IDEA: XBRL DOCUMENT v3.22.1
Share Capital - Warrant Plans (Details)
12 Months Ended
Dec. 31, 2021
shares
patient
€ / shares
Apr. 20, 2021
shares
€ / shares
Mar. 17, 2020
shares
€ / shares
Mar. 29, 2019
€ / shares
Dec. 31, 2021
shares
€ / shares
Dec. 31, 2020
shares
€ / shares
Dec. 31, 2019
€ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Par value per share (euro per share) | € / shares € 0.03       € 0.03 € 0.03 € 0.03
BSA 2021 (a)              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Issued (in shares)   48,103     48,103    
Exercise price (in euros per share) | € / shares   € 13.47   € 13.47      
BSPCE exercise (in shares)         0    
BSA 2021 (a) | Supervisory Board              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Issued (in shares)   48,103          
Number of ordinary share subscribed per each BSA (in shares)   1          
Par value per share (euro per share) | € / shares   € 0.03          
Exercise price (in euros per share) | € / shares   € 13.47          
BSPCE exercise (in shares) 14,431            
Maximum term of other equity instruments granted for share-based payment arrangement 10 years            
Vesting requirements, minimum attendance 75.00%            
Vesting requirements, attendance period 12 months            
Vesting requirements, recommended dose determination, minimum number of patients | patient 2            
Vesting requirements, recommended dose determination, total number of patients enrolled | patient 3            
BSA 2021 (a) | External Consultant              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Issued (in shares)   30,000          
Number of ordinary share subscribed per each BSA (in shares)   1          
Par value per share (euro per share) | € / shares   € 0.03          
Exercise price (in euros per share) | € / shares   € 13.64          
BSPCE exercise (in shares) 0            
Maximum term of other equity instruments granted for share-based payment arrangement   10 years          
BSA 2021 (a) In Replacement Of BSA 2016 | Supervisory Board              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Issued (in shares)   18,103          
BSA 2020              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Issued (in shares)     18,000   0 18,000  
Par value per share (euro per share) | € / shares     € 0.03        
Exercise price (in euros per share) | € / shares     € 6.59        
BSPCE exercise (in shares)         0 0